Want to see RXST full AI Analyst Report?
RxSight (RXST) Ratios
249 Followers
RxSight Ratios
RXST's free cash flow for Q3 2026 was $44.04M. For the 2026 fiscal year, RXST's free cash flow was decreased by $-1.17M and operating cash flow was $45.22M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.95 | 11.36 | 8.06 | 7.81 | 15.92 |
| Quick Ratio | 9.75 | 10.50 | 7.22 | 6.95 | 15.19 |
| Cash Ratio | 0.76 | 0.65 | 0.46 | 0.69 | 2.20 |
| Solvency Ratio | -0.99 | -0.64 | -2.00 | -1.04 | -0.82 |
| Operating Cash Flow Ratio | -0.59 | -0.65 | -1.99 | -3.41 | -4.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -17.40 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 251.33M | $ 256.50M | $ 146.22M | $ 74.29M | $ 121.82M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.02 | 0.30 | 0.23 |
| Debt-to-Equity Ratio | 0.04 | 0.04 | 0.02 | 0.50 | 0.33 |
| Debt-to-Capital Ratio | 0.04 | 0.04 | 0.02 | 0.33 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.31 | 0.22 |
| Financial Leverage Ratio | 1.13 | 1.13 | 1.14 | 1.67 | 1.39 |
| Debt Service Coverage Ratio | -890.90 | -23.93 | -12.41 | -11.68 | -11.14 |
| Interest Coverage Ratio | -1204.75 | -1755.14 | -15.14 | -12.80 | -14.34 |
| Debt to Market Cap | 0.02 | 0.00 | 0.00 | 0.11 | 0.13 |
| Interest Debt Per Share | 0.27 | 0.32 | 0.18 | 1.81 | 1.78 |
| Net Debt to EBITDA | 0.25 | 0.19 | 0.16 | -0.57 | -0.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 76.60% | 70.71% | 60.36% | 43.52% | 19.99% |
| EBIT Margin | -28.88% | -19.57% | -50.83% | -126.11% | -199.17% |
| EBITDA Margin | -26.45% | -16.98% | -46.07% | -117.90% | -181.52% |
| Operating Profit Margin | -35.84% | -26.34% | -56.23% | -129.21% | -233.64% |
| Pretax Profit Margin | -28.91% | -19.59% | -54.55% | -136.20% | -215.46% |
| Net Profit Margin | -28.96% | -19.62% | -54.57% | -136.22% | -215.50% |
| Continuous Operations Profit Margin | -28.96% | -19.62% | -54.57% | -136.22% | -215.50% |
| Net Income Per EBT | 100.17% | 100.18% | 100.04% | 100.01% | 100.02% |
| EBT Per EBIT | 80.67% | 74.35% | 97.01% | 105.42% | 92.22% |
| Return on Assets (ROA) | -12.49% | -8.62% | -26.63% | -44.46% | -25.26% |
| Return on Equity (ROE) | -14.13% | -9.76% | -30.31% | -74.25% | -35.22% |
| Return on Capital Employed (ROCE) | -16.88% | -12.59% | -30.98% | -47.63% | -29.06% |
| Return on Invested Capital (ROIC) | -16.81% | -12.55% | -30.64% | -46.94% | -28.82% |
| Return on Tangible Assets | -12.49% | -8.62% | -26.63% | -44.46% | -25.26% |
| Earnings Yield | -9.08% | -2.05% | -3.50% | -19.05% | -15.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.75 | 4.66 | 4.39 | 4.47 | 4.65 |
| Payables Turnover | 5.94 | 9.02 | 9.14 | 10.67 | 10.70 |
| Inventory Turnover | 1.00 | 1.86 | 2.03 | 1.87 | 2.25 |
| Fixed Asset Turnover | 5.84 | 5.92 | 6.71 | 3.48 | 1.46 |
| Asset Turnover | 0.43 | 0.44 | 0.49 | 0.33 | 0.12 |
| Working Capital Turnover Ratio | 0.51 | 0.67 | 0.67 | 0.35 | 0.19 |
| Cash Conversion Cycle | 368.08 | 233.93 | 223.24 | 243.02 | 206.63 |
| Days of Sales Outstanding | 63.47 | 78.39 | 83.10 | 81.60 | 78.55 |
| Days of Inventory Outstanding | 366.04 | 196.01 | 180.07 | 195.64 | 162.19 |
| Days of Payables Outstanding | 61.43 | 40.47 | 39.93 | 34.22 | 34.11 |
| Operating Cycle | 429.51 | 274.40 | 263.17 | 277.24 | 240.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.38 | -0.44 | -1.21 | -2.13 | -1.63 |
| Free Cash Flow Per Share | -0.47 | -0.58 | -1.35 | -2.21 | -1.70 |
| Dividend Paid and CapEx Coverage Ratio | -4.05 | -3.12 | -8.64 | -24.59 | -23.05 |
| Capital Expenditure Coverage Ratio | -4.05 | -3.12 | -8.64 | -24.59 | -23.05 |
| Operating Cash Flow Coverage Ratio | -1.40 | -1.38 | -13.81 | -1.31 | -1.00 |
| Operating Cash Flow to Sales Ratio | -0.12 | -0.12 | -0.47 | -1.20 | -1.98 |
| Free Cash Flow Yield | -4.51% | -1.68% | -3.34% | -17.47% | -15.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.97 | -48.42 | -28.58 | -5.25 | -6.32 |
| Price-to-Sales (P/S) Ratio | 3.19 | 9.55 | 15.60 | 7.15 | 13.63 |
| Price-to-Book (P/B) Ratio | 1.56 | 4.75 | 8.66 | 3.90 | 2.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -22.18 | -59.69 | -29.94 | -5.72 | -6.60 |
| Price-to-Operating Cash Flow Ratio | -27.66 | -78.85 | -33.40 | -5.96 | -6.89 |
| Price-to-Earnings Growth (PEG) Ratio | -0.32 | 0.98 | 0.69 | -0.15 | 0.01 |
| Enterprise Value Multiple | -11.81 | -56.05 | -33.69 | -6.64 | -8.01 |
| Enterprise Value | 420.14M | 1.33B | 1.38B | 383.64M | 328.45M |
| EV to EBITDA | -11.81 | -56.05 | -33.69 | -6.64 | -8.01 |
| EV to Sales | 3.12 | 9.52 | 15.52 | 7.83 | 14.54 |
| EV to Free Cash Flow | -21.72 | -59.50 | -29.79 | -6.26 | -7.04 |
| EV to Operating Cash Flow | -27.09 | -78.59 | -33.24 | -6.52 | -7.35 |
| Tangible Book Value Per Share | 6.70 | 7.24 | 4.65 | 3.25 | 5.05 |
| Shareholders’ Equity Per Share | 6.70 | 7.24 | 4.65 | 3.25 | 5.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 3.27 | 3.60 | 2.59 | 1.77 | 0.83 |
| Net Income Per Share | -0.95 | -0.71 | -1.41 | -2.41 | -1.78 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.07 | 1.08 | 1.08 |
| Research & Development to Revenue | 0.29 | 0.25 | 0.33 | 0.53 | 1.08 |
| SG&A to Revenue | 0.84 | 0.72 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.24 | 0.18 | 0.18 | 0.23 | 0.34 |
| Income Quality | 0.40 | 0.62 | 0.86 | 0.88 | 0.92 |
Currency in USD
